scholarly article | Q13442814 |
P819 | ADS bibcode | 2011PLoSO...624514K |
P356 | DOI | 10.1371/JOURNAL.PONE.0024514 |
P932 | PMC publication ID | 3174186 |
P698 | PubMed publication ID | 21935415 |
P5875 | ResearchGate publication ID | 51659236 |
P50 | author | Naoya Sakamoto | Q89436415 |
P2093 | author name string | Taisuke Inoue | |
Mamoru Watanabe | |||
Nobuyuki Enomoto | |||
Fumitake Amemiya | |||
Minoru Sakamoto | |||
Shinya Maekawa | |||
Mika Miura | |||
Tomoyoshi Uetake | |||
Mina Nakagawa | |||
Hiroko Shindo | |||
Kazuki Komase | |||
Makoto Kadokura | |||
Ryota Sueki | |||
P2860 | cites work | Clinical relevance of hepatitis C virus genotypes | Q27469323 |
Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation | Q27469500 | ||
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection | Q27477830 | ||
Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy | Q27481007 | ||
Contribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American Patients | Q27490885 | ||
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 | ||
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study | Q28269827 | ||
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose | Q29547886 | ||
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C | Q29619541 | ||
Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection | Q29620702 | ||
Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial | Q42008293 | ||
Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy | Q42978970 | ||
Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa | Q42981557 | ||
Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy | Q42984548 | ||
Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. | Q42985033 | ||
Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. | Q42988613 | ||
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 2a high viral load and virological response to interferon-ribavirin combination therapy. | Q42990686 | ||
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy. | Q42993815 | ||
Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy | Q42994454 | ||
Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection | Q42995344 | ||
Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy | Q43000728 | ||
Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors | Q43031629 | ||
Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon | Q43037816 | ||
Analysis of the complete open reading frame of hepatitis C virus in genotype 2a infection reveals critical sites influencing the response to peginterferon and ribavirin therapy | Q45367431 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Hepatitis C virus | Q708693 |
ribavirin | Q421862 | ||
P304 | page(s) | e24514 | |
P577 | publication date | 2011-09-15 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapy | |
P478 | volume | 6 |
Q33982230 | HCV genome-wide genetic analyses in context of disease progression and hepatocellular carcinoma |
Q38224436 | Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview |
Q35230421 | Prediction of hepatitis C virus interferon/ribavirin therapy outcome based on viral nucleotide attributes using machine learning algorithms |
Q35826594 | Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1. |
Q39157496 | Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype. |
Q37362240 | Role of viral and host factors in interferon based therapy of hepatitis C virus infection |
Search more.